SXTP Stock Analysis: Buy, Sell, or Hold?
SXTP - 60 Degrees Pharmaceuticals, Inc. Common Stock
$1.51
0.01 (0.67%)
▲
5d:
-17.49%
30d:
-51.45%
90d:
+116.95%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When SXTP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SXTP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SXTP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SXTP is currently trading at $1.51, which is considered oversold relative to its 30-day fair value range of $1.73 to $2.93.
Technical Outlook: Technically, SXTP is in a uptrend. Immediate support is located at $1.29, while resistance sits at $2.46.
Market Sentiment: SXTP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.60 (+1065.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SXTP is in a uptrend. Immediate support is located at $1.29, while resistance sits at $2.46.
Market Sentiment: SXTP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.60 (+1065.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.73 -
$2.93
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 1065.6% below Wall St target ($17.60)
- CAUTION: 5-day price weakness (-17.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.73 -
$2.93
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.29
Resistance Level
$2.46
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.19
Wall Street Target
$17.60
(+1065.6%)
Revenue Growth (YoY)
256.9%
Share & Embed Analysis
Last updated: March 30, 2026 5:59 PM ET
Data refreshes hourly during market hours. Next update: 6:59 PM
Data refreshes hourly during market hours. Next update: 6:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTP showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Geoffrey S Dow
BUY
2417 shares
2025-12-15
Geoffrey S Dow
BUY
903 shares
2025-12-11
Geoffrey S Dow
BUY
2337 shares
2025-12-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 58 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 67 BUY |
